Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol S Lim

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Molecular Pharmaceutics|May 20, 2014
Re-engineered p53 chimera with enhanced homo-oligomerization that maintains tumor suppressor activityAbood Okal, Sean Cornillie, Stephan J Matissek, et al.
The Primary Care Companion for CNS Disorders|November 7, 2025
Choosing a Pharmacologic Strategy for Those With a Psychotic Illness: Balancing Efficacy, Tolerability, and CostCarol S Lim, Alejandra Morfin Rodriguez, Abigail L Donovan, et al.
Journal of Ovarian Research|May 17, 2019
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53Phong Lu, Erica R Vander Mause, Katherine E Redd Bowman, et al.
The Primary Care Companion for CNS Disorders|July 12, 2024
Treatment-Resistant Schizophrenia: Evaluation and ManagementCarol S Lim, Abigail L Donovan, Chirag M Vyas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
The Primary Care Companion for CNS Disorders|November 26, 2024
Tardive Dyskinesia: Etiology, Prevention, and ManagementNicholas O Daneshvari, Chirag M Vyas, Carol S Lim, et al.
The Primary Care Companion for CNS Disorders|August 2, 2024
Clozapine: Its Use and MonitoringDesta S Lissanu, Chirag M Vyas, Carol S Lim, et al.
Molecular Pharmaceutics|August 15, 2025
Mitochondrially Targeted p53-Bad* Fusion Gene Therapy Promotes Apoptosis in Hepatocellular Carcinoma by Pan-Bcl-2 InhibitionBraxten D Hornsby, Julius K K Tuekpe, Cassidy A Steele, et al.
The Journal of Biological Chemistry|June 11, 2011
Disruption of Bcr-Abl coiled coil oligomerization by designAndrew S Dixon, Scott S Pendley, Benjamin J Bruno, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 28, 2017
Application of Thiol-yne/Thiol-ene Reactions for Peptide and Protein MacrocyclizationsYuanxiang Wang, Benjamin J Bruno, Sean Cornillie, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Molecular Pharmaceutics|May 20, 2014
Re-engineered p53 chimera with enhanced homo-oligomerization that maintains tumor suppressor activityAbood Okal, Sean Cornillie, Stephan J Matissek, et al.
The Primary Care Companion for CNS Disorders|November 7, 2025
Choosing a Pharmacologic Strategy for Those With a Psychotic Illness: Balancing Efficacy, Tolerability, and CostCarol S Lim, Alejandra Morfin Rodriguez, Abigail L Donovan, et al.
Journal of Ovarian Research|May 17, 2019
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53Phong Lu, Erica R Vander Mause, Katherine E Redd Bowman, et al.
The Primary Care Companion for CNS Disorders|July 12, 2024
Treatment-Resistant Schizophrenia: Evaluation and ManagementCarol S Lim, Abigail L Donovan, Chirag M Vyas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
The Primary Care Companion for CNS Disorders|November 26, 2024
Tardive Dyskinesia: Etiology, Prevention, and ManagementNicholas O Daneshvari, Chirag M Vyas, Carol S Lim, et al.
The Primary Care Companion for CNS Disorders|August 2, 2024
Clozapine: Its Use and MonitoringDesta S Lissanu, Chirag M Vyas, Carol S Lim, et al.
Molecular Pharmaceutics|August 15, 2025
Mitochondrially Targeted p53-Bad* Fusion Gene Therapy Promotes Apoptosis in Hepatocellular Carcinoma by Pan-Bcl-2 InhibitionBraxten D Hornsby, Julius K K Tuekpe, Cassidy A Steele, et al.
The Journal of Biological Chemistry|June 11, 2011
Disruption of Bcr-Abl coiled coil oligomerization by designAndrew S Dixon, Scott S Pendley, Benjamin J Bruno, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 28, 2017
Application of Thiol-yne/Thiol-ene Reactions for Peptide and Protein MacrocyclizationsYuanxiang Wang, Benjamin J Bruno, Sean Cornillie, et al.
Pageof 6